OncoThira and NDSU enter into license agreement to develop, market cancer compounds

OncoThira and NDSU enter into license agreement to develop, market cancer compounds The NDSU Research Foundation and OncoThira have entered into a license agreement involving technology developed at North Dakota State University (NDSU). OncoThira will develop and market compounds discovered by NDSU pharmaceutical sciences researcher Steven Qian for the treatment of cancer. The main compound…
Read more